TrialCardiovascular drugs and therapy2009

Selective PKC beta inhibition with ruboxistaurin and endothelial function in type-2 diabetes mellitus.

Nehal N Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.